[Skip to Content]
[Skip to Content Landing]
Citations 0
Letters
May 27, 1998

Genetic Testing for Susceptibility to Cancer

Author Affiliations
 

Margaret A.WinkerMD, Senior EditorIndividualAuthorPhil B.FontanarosaMD, Senior EditorIndividualAuthor

JAMA. 1998;279(20):1612-1613. doi:10-1001/pubs.JAMA-ISSN-0098-7484-279-20-jbk0527

To the Editor.—The Policy Perspective by Dr Kodish and colleagues1 summarizes important clinical considerations regarding genetic testing for breast cancer susceptibility. The authors endorse the statement of the American Society of Clinical Oncology (ASCO)2 that further research in this area is essential, but argue that restricting genetic testing to the research setting may not be in the patient's best interest. In this regard, it is perhaps worth noting that testing for cancer genetic susceptibility is now being marketed by more than a dozen commercial laboratories.

First Page Preview View Large
First page PDF preview
First page PDF preview
×